Taiwan Shilin District Court appeals against the acquittal of Mr. Michael Chang and five other executives’insider trading case

Supplementary statement regarding the news article by the Investor and other news media
June 27, 2019
  1. Parties to the legal matter: Michael Chang (Chairman); Youe-Kong Shue (Former Vice Chairman); Amy Hung (General Manager); Tony Yu (Chief Science Officer); Jon-Jin Liao (Former Medical Business Director)
  2. Name of the court or disposing agency: Taiwn Shilin District Court
  3. Reference/case numbers of relevant documents: NA
  4. Date of occurrence of the event: Jul 11, 2019
  5. Background and circumstances of the matter (including the property/subject matter under dispute): Prosecutor appeals against Mr. Michael Chang and five other executives’ acquittal for insider trading case on Jun 21, 2019.
    https://www.slc.moj.gov.tw/293537/293550/293551/703908/post
  6. Course and progression of handling of the matter: None
  7. Effect on company finances and business and estimated monetary amount of the effect: Company is under regular operation and the event does not have any significant impact on company’s financial status.
  8. Countermeasures and status of amelioration: Parties will entrust lawyer to deal with the situation.
  9. Any other matters that need to be specified: New drug development is a long process associated with high cost. It is not a guaranteed success, which may increase the risk of investment. Investors shall make prudent judgments and investments.